Article ID Journal Published Year Pages File Type
5699453 Clinical Oncology 2009 9 Pages PDF
Abstract
There was general support for dose-banding, but concerns about the lack of an evidence base could be a barrier to the wider introduction of the system. Consequently, more clinical studies are required to justify the safety and efficacy of dose-banding, and also to evaluate whether dose-banding is acceptable within clinical trials.
Related Topics
Health Sciences Medicine and Dentistry Oncology
Authors
, ,